A 39-year-old woman comes to the clinic reporting heavy, irregular vaginal bleeding for the past 6 months. Prior to the onset of this bleeding, she had not menstruated for 9 months. Menarche was at age 12, and her menses have historically occurred only 3 to 4 times per year. She has a history of severe facial acne and hirsutism. Her medical history is otherwise unremarkable, and she does not take any medications. Her BMI is . Vital signs are within normal limits. Pelvic examination demonstrates normal external genitalia and a normal-appearing cervix. Bimanual examination reveals a normal-sized, mobile uterus and no adnexal masses. A urine pregnancy test is negative. Which of the following is the most appropriate next step in management?
- APerform transvaginal ultrasonography
- BPrescribe combined oral contraceptive pills
- Perform an endometrial biopsyCevap
- DMeasure serum luteinizing hormone and follicle-stimulating hormone levels
- ESchedule a hysteroscopic endometrial ablation
Cevap
Perform an endometrial biopsy
The correct answer is to perform an endometrial biopsy. This patient presents with abnormal uterine bleeding in the setting of chronic anovulation (suggested by a history of oligo-ovulation, acne, and hirsutism consistent with polycystic ovary syndrome) and severe obesity. Both chronic anovulation and obesity (due to the peripheral aromatization of androgens to estrogens in excess adipose tissue) lead to continuous, unopposed estrogen stimulation of the endometrium. This state significantly increases the risk of developing endometrial hyperplasia and endometrial adenocarcinoma. Current guidelines mandate that premenopausal women (< 45 years) with abnormal uterine bleeding and additional risk factors for unopposed estrogen exposure (such as obesity, chronic anovulation, or failed medical management) must undergo an endometrial biopsy to rule out malignancy. A tissue diagnosis is strictly required before initiating any long-term medical or surgical therapy.
Adım Adım Çözüm
Anahtar Kavram
Endometrial biopsy is indicated to evaluate for endometrial hyperplasia or cancer in premenopausal women (< 45 years) who present with abnormal uterine bleeding and have risk factors for unopposed estrogen exposure, such as obesity or chronic anovulation (e.g., Polycystic Ovary Syndrome).